JP2003528628A5 - - Google Patents

Download PDF

Info

Publication number
JP2003528628A5
JP2003528628A5 JP2001570845A JP2001570845A JP2003528628A5 JP 2003528628 A5 JP2003528628 A5 JP 2003528628A5 JP 2001570845 A JP2001570845 A JP 2001570845A JP 2001570845 A JP2001570845 A JP 2001570845A JP 2003528628 A5 JP2003528628 A5 JP 2003528628A5
Authority
JP
Japan
Prior art keywords
sample
gcc
gastric
esophageal cancer
translation product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2001570845A
Other languages
English (en)
Other versions
JP2003528628A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/009790 external-priority patent/WO2001073132A1/en
Publication of JP2003528628A publication Critical patent/JP2003528628A/ja
Publication of JP2003528628A5 publication Critical patent/JP2003528628A5/ja
Ceased legal-status Critical Current

Links

Description

【特許請求の範囲】
【請求項1】 原発性および/または転移性の胃癌または食道癌を伴う疑いがある個体を原発性および/または転移性の胃癌または食道癌の細胞についてスクリーニングするインビトロ方法であって、個体からの腸外組織および/または体液の試料を検査して、該試料中の細胞がGCCを発現しているか判定する工程を含み、その際、GCCの発現は試料中に原発性および/または転移性の胃癌または食道癌の細胞がある可能性を指示するものである方法。
【請求項2】 細胞によるGCCの発現を、GCC遺伝子転写生成物の存在を検出することにより判定する、請求項1に記載の方法。
【請求項3】 細胞によるGCCの発現を、試料とGCC遺伝子転写体またはそれから形成されたcDNAを選択的に増幅するプライマーとを接触させるポリメラーゼ連鎖反応により判定する、請求項1に記載の方法。
【請求項4】 細胞によるGCCの発現を、試料とGCC遺伝子翻訳生成物に特異的に結合する抗体とを接触させる免疫アッセイにより判定する、請求項1に記載の方法。
【請求項5】 試料が体液である、請求項1に記載の方法。
【請求項6】 試料が血液である、請求項1に記載の方法。
【請求項7】 試料がリンパ組織および/またはリンパ液である、請求項1に記載の方法。
【請求項8】 試料がリンパ節試料である、請求項1に記載の方法。
【請求項9】 個体が胃癌または食道癌を伴うと予め診断されている、請求項1に記載の方法。
【請求項10】 個体が胃癌または食道癌を伴うと以前に診断され、かつそれに対する処置を受けたことがある、請求項1に記載の方法。
【請求項11】 原発性および/または転移性の胃癌または食道癌を伴う疑いがある個体を原発性および/または転移性の胃癌または食道癌の細胞についてスクリーニングするインビトロ方法であって、個体からの腸外組織および/または体液の試料を検査して、該試料中にGCC遺伝子転写または翻訳生成物が存在するか判定する工程を含み、その際、該試料中のGCC遺伝子転写または翻訳生成物の存在はその個体が試料中に原発性および/または転移性の胃癌または食道癌の細胞を有する可能性を指示するものである方法。
【請求項12】 個体からの腸外組織および/または体液の試料を検査して、該試料中にGCC遺伝子転写生成物が存在するか判定する工程を含む、請求項10に記載の方法。
【請求項13】 GCC遺伝子転写生成物の存在を、試料とGCC遺伝子転写体またはそれから形成されたcDNAを選択的に増幅するプライマーとを接触させるポリメラーゼ連鎖反応により判定する、請求項12に記載の方法。
【請求項14】 GCC遺伝子翻訳生成物の存在を、試料とGCC遺伝子翻訳生成物に特異的に結合する抗体とを接触させる免疫アッセイにより判定する、請求項11に記載の方法。
【請求項15】 試料が体液である、請求項11に記載の方法。
【請求項16】 試料が血液である、請求項11に記載の方法。
【請求項17】 試料がリンパ組織および/またはリンパ液である、請求項11に記載の方法。
【請求項18】 試料がリンパ節試料である、請求項11に記載の方法。
【請求項19】 個体が胃癌または食道癌を伴うと以前に診断されたことがある、請求項11に記載の方法。
【請求項20】 個体が胃癌または食道癌を伴うと以前に診断され、かつそれに対する処置を受けたことがある、請求項11に記載の方法。
【請求項21】 胃癌または食道癌の細胞を有する疑いがある患者から採取した腫瘍細胞が胃または食道の腫瘍細胞であることを確認するインビトロ方法であって、腫瘍細胞がGCCを発現するか判定する工程を含み、その際、GCCの発現は該腫瘍細胞が胃または食道の腫瘍細胞であることを指示するものである方法。
【請求項22】 腫瘍細胞によるGCCの発現を、GCC遺伝子転写生成物の存在の検出により判定する、請求項21に記載の方法。
【請求項23】 腫瘍細胞によるGCCの発現を、腫瘍細胞からのmRNAまたはそれから形成されたcDNAとGCC遺伝子転写体またはそれから形成されたcDNAを選択的に増幅するプライマーとを接触させるポリメラーゼ連鎖反応により判定する、請求項21に記載の方法。
【請求項24】 腫瘍細胞によるGCCの発現を、腫瘍細胞からのタンパク質とGCC遺伝子翻訳生成物に特異的に結合する抗体とを接触させる免疫アッセイにより判定する、請求項21に記載の方法。
【請求項25】 胃癌を伴う個体の診断方法であって、胃組織の試料を検査してGCC転写体または翻訳生成物の存在を検出する工程を含み、その際、胃試料中におけるGCC転写体または翻訳生成物の存在は胃癌を指示するものである方法。
【請求項26】 胃組織の試料を検査して該試料中にGCC遺伝子転写生成物が存在するか判定する工程を含む、請求項25に記載の方法。
【請求項27】 GCC遺伝子転写生成物の存在を、試料とGCC遺伝子転写体またはそれから形成されたcDNAを選択的に増幅するプライマーとを接触させるポリメラーゼ連鎖反応により判定する、請求項26に記載の方法。
【請求項28】 GCC遺伝子翻訳生成物の存在を、試料とGCC遺伝子翻訳生成物に特異的に結合する抗体とを接触させる免疫アッセイにより判定する、請求項26に記載の方法。
【請求項29】 食道癌を伴う個体の診断方法であって、食道組織の試料を検査してGCC転写体または翻訳生成物の存在を検出する工程を含み、その際、食道試料中におけるGCC転写体または翻訳生成物の存在は食道癌を指示するものである方法。
【請求項30】 食道組織の試料を検査して該試料中にGCC遺伝子転写生成物が存在するか判定する工程を含む、請求項29に記載の方法。
【請求項31】 GCC遺伝子転写生成物の存在を、試料とGCC遺伝子転写体またはそれから形成されたcDNAを選択的に増幅するプライマーとを接触させるポリメラーゼ連鎖反応により判定する、請求項30に記載の方法。
【請求項32】 GCC遺伝子翻訳生成物の存在を、試料とGCC遺伝子翻訳生成物に特異的に結合する抗体とを接触させる免疫アッセイにより判定する、請求項29に記載の方法。
【請求項33】 胃癌および/または食道癌を伴う個体を診断するための、下記のいずれかを含むキット:
a)GCC遺伝子転写体またはそれから形成されたcDNAを選択的に増幅するポリメラーゼ連鎖反応プライマーを含む容器;
ならびに下記のうち1以上:
陽性PCRアッセイ対照試料を含む容器、
陰性PCRアッセイ対照試料を含む容器、
試料を入手および/または処理するための指示書、
PCR診断アッセイを実施するための指示書、ならびに
PCR診断アッセイの陽性結果および/または陰性結果を表わす写真または図;
あるいは
b)GCC遺伝子翻訳生成物に特異的に結合する抗体を含む容器;
ならびに下記のうち1以上:
陽性免疫アッセイ対照試料を含む容器、
陰性免疫アッセイ対照試料を含む容器、
試料を入手および/または処理するための指示書、
免疫診断アッセイを実施するための指示書、ならびに
免疫診断アッセイの陽性結果および/または陰性結果を表わす写真または図。
【請求項34】 原発性および/または転移性の胃癌または食道癌に罹患している疑いがある個体を処置するための医薬組成物であって、
i)ST受容体リガンド;および
ii)有効物質
を含む有効量の組成物を含む前記医薬組成物
【請求項35】 ST受容体リガンドが有効物質にコンジュゲートしている、請求項34に記載の医薬組成物
【請求項36】 有効物質が、メトトレキセート、ドキソルビシン、ダウノルビシン、シトシンアラビノシド、エトポシド、5−4フルオロウラシル、メルファラン、クロラムブシル、シスプラチン、ビンデシン、マイトマイシン、ブレオマイシン、ピューロチオニン、マクロモマイシン、1,4−ベンゾキノン誘導体、トレニモン、リシン、リシンA鎖、シュードモナス外毒素、ジフテリア毒素、クロストリジウム・パーフリンジェンスホスホリパーゼC、ウシ膵臓リボヌクレアーゼ、アメリカヤマゴボウ抗ウイルスタンパク質、アブリン、アブリンA鎖、コブラ毒因子、ゲロニン、サポリン、モデッシン、ビスキュミン、ボルケンシン、アルカリ性ホスファターゼ、ニトロイミダゾール、メトロニダゾール、ミソニダゾール、
【化1】
Figure 2003528628
よりなる群から選択される、請求項34に記載の医薬組成物
【請求項37】 原発性および/または転移性の胃癌または食道癌の細胞のラジオイメージング方法であって、検出可能な物質に結合したST受容体リガンドを含む組成物を個体に投与する工程を含む方法。
【請求項38】 検出可能な物質が
【化2】
Figure 2003528628
よりなる群から選択される、請求項37に記載の方法。
JP2001570845A 2000-03-27 2001-03-27 消化管由来の癌細胞を同定およびターゲティングするための組成物および方法 Ceased JP2003528628A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19222900P 2000-03-27 2000-03-27
US60/192,229 2000-03-27
PCT/US2001/009790 WO2001073132A1 (en) 2000-03-27 2001-03-27 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin

Publications (2)

Publication Number Publication Date
JP2003528628A JP2003528628A (ja) 2003-09-30
JP2003528628A5 true JP2003528628A5 (ja) 2008-05-22

Family

ID=22708782

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2001570845A Ceased JP2003528628A (ja) 2000-03-27 2001-03-27 消化管由来の癌細胞を同定およびターゲティングするための組成物および方法
JP2001570846A Expired - Fee Related JP5122713B2 (ja) 2000-03-27 2001-03-27 癌細胞を同定およびターゲティングするための組成物および方法
JP2001570844A Pending JP2003535580A (ja) 2000-03-27 2001-03-27 高特異性マーカー検出

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2001570846A Expired - Fee Related JP5122713B2 (ja) 2000-03-27 2001-03-27 癌細胞を同定およびターゲティングするための組成物および方法
JP2001570844A Pending JP2003535580A (ja) 2000-03-27 2001-03-27 高特異性マーカー検出

Country Status (10)

Country Link
US (20) US6767704B2 (ja)
EP (6) EP3388534A1 (ja)
JP (3) JP2003528628A (ja)
AT (2) ATE469242T1 (ja)
AU (3) AU2001249548A1 (ja)
CA (3) CA2404431C (ja)
DE (2) DE60140865D1 (ja)
ES (2) ES2548381T3 (ja)
PT (1) PT1272665E (ja)
WO (3) WO2001073132A1 (ja)

Families Citing this family (124)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7097839B1 (en) * 1993-10-26 2006-08-29 Thomas Jefferson University ST receptor binding compounds and methods of using the same
US5879656A (en) * 1993-10-26 1999-03-09 Thomas Jefferson University Methods of treating metastatic colorectal cancer with ST receptor binding compounds
US6692952B1 (en) * 1999-11-10 2004-02-17 Massachusetts Institute Of Technology Cell analysis and sorting apparatus for manipulation of cells
CA2404431C (en) * 2000-03-27 2011-06-07 Thomas Jefferson University Guanylyl cyclase c in the detection of stomach and esophageal cancers
US7829276B2 (en) * 2000-09-18 2010-11-09 Thomas Jefferson University Methods of using CRCA-1 as a stomach and esophageal cancer marker
US20030148295A1 (en) * 2001-03-20 2003-08-07 Wan Jackson Shek-Lam Expression profiles and methods of use
WO2004029221A2 (en) * 2002-09-27 2004-04-08 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
US20040146907A1 (en) * 2002-11-13 2004-07-29 Genentech, Inc. Methods and compositions for detecting dysplasia
DE10259703A1 (de) * 2002-12-19 2004-07-08 Ivonex Gmbh Trennungsverfahren
US7422865B2 (en) * 2003-01-13 2008-09-09 Agilent Technologies, Inc. Method of identifying peptides in a proteomic sample
EP1599165A4 (en) * 2003-02-10 2010-09-08 Univ Jefferson THE USE OF GCC LIGANDS
EP1604184A4 (en) * 2003-02-27 2010-10-27 Stephen A Lesko STANDARDIZED EVALUATION OF THERAPEUTIC EFFICIENCY BASED ON CELLULAR BIOMARKERS
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
WO2004113877A1 (en) * 2003-06-13 2004-12-29 The General Hospital Corporation Microfluidic systems for size based removal of red blood cells and platelets from blood
AU2004251890B2 (en) * 2003-06-25 2010-09-23 Crucell Holland B.V. Binding molecules for the treatment of myeloid cell malignancies
EP1649062B1 (en) * 2003-07-03 2009-12-09 Gentron, LLC. Methods and systems for diagnosis of non-central nervous system (cns) diseases in cns samples
DK1670511T3 (da) * 2003-09-15 2009-11-23 Res Dev Foundation Cripto-antagonisme af activin- og TGF-B-signalering
WO2005040163A1 (en) * 2003-10-28 2005-05-06 Dr. Reddy's Laboratories Ltd Heterocyclic compounds that block the effects of advanced glycation end products (age)
US8969372B2 (en) 2003-11-14 2015-03-03 Aptose Boisciences Inc. Aryl imidazoles and their use as anti-cancer agents
WO2005084374A2 (en) * 2004-03-03 2005-09-15 The General Hospital Corporation Magnetic device for isolation of cells and biomolecules in a microfluidic environment
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
EP2722060A3 (en) 2004-06-25 2015-01-07 Thomas Jefferson University Guanylyl cyclase C ligands
AU2005271960B2 (en) * 2004-07-09 2011-12-08 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Identification of markers in lung and breast cancer
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
US8535914B2 (en) * 2005-01-21 2013-09-17 Canon Kabushiki Kaisha Probe, probe set and information acquisition method using the same
US20070026417A1 (en) * 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026415A1 (en) * 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026413A1 (en) * 2005-07-29 2007-02-01 Mehmet Toner Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070196820A1 (en) 2005-04-05 2007-08-23 Ravi Kapur Devices and methods for enrichment and alteration of cells and other particles
US20070026414A1 (en) * 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20090181421A1 (en) * 2005-07-29 2009-07-16 Ravi Kapur Diagnosis of fetal abnormalities using nucleated red blood cells
US20070059680A1 (en) * 2005-09-15 2007-03-15 Ravi Kapur System for cell enrichment
US20070026416A1 (en) * 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US8921102B2 (en) * 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
WO2007030473A2 (en) * 2005-09-06 2007-03-15 Stanford University Luciferases and methods for making and using the same
US20070059683A1 (en) * 2005-09-15 2007-03-15 Tom Barber Veterinary diagnostic system
US20070059781A1 (en) * 2005-09-15 2007-03-15 Ravi Kapur System for size based separation and analysis
US20070059774A1 (en) * 2005-09-15 2007-03-15 Michael Grisham Kits for Prenatal Testing
US20100260465A1 (en) * 2005-12-22 2010-10-14 Pacific Biosciences Of California, Inc. Protein engineering strategies to optimize activity of surface attached proteins
EP1963530B1 (en) * 2005-12-22 2011-07-27 Pacific Biosciences of California, Inc. Active surface coupled polymerases
EP3056575B1 (en) * 2005-12-22 2017-10-11 Pacific Biosciences Of California, Inc. Polymerases for nucleotide analogue incorporation
EP1984738A2 (en) 2006-01-11 2008-10-29 Raindance Technologies, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
JP2007215412A (ja) * 2006-02-14 2007-08-30 Shizuoka Prefecture 悪性転移性胃癌の判定方法
US20070207467A1 (en) * 2006-03-01 2007-09-06 Ming Xu Detection of lymph node metastasis from gastric carcinoma
EP2481815B1 (en) 2006-05-11 2016-01-27 Raindance Technologies, Inc. Microfluidic devices
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
BRPI0713098A2 (pt) * 2006-05-22 2012-10-16 Clinical Genomics Pty Ltd método para determinar a origem anatÈmica de uma célula ou população celular derivada do intestino grosso de um indivìduo, método de detecção para determinar a origem anatÈmica de uma célula ou população celular derivada do intestino grosso de um indivìduo, sistema de detecção, meio de armazenagem legìvel por computador, arranjo de ácido nucleico, uso de um arranjo, método para determinar o inìcio ou predisposição para o inìcio de uma anormalidade celular ou uma condição destinguida por uma anormalidade celular no intestino grosso, kit de diagnóstico para ensaiar amostras biológicas
US8372584B2 (en) 2006-06-14 2013-02-12 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
WO2007147074A2 (en) * 2006-06-14 2007-12-21 Living Microsystems, Inc. Use of highly parallel snp genotyping for fetal diagnosis
US20080050739A1 (en) * 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
EP3536396B1 (en) 2006-08-07 2022-03-30 The President and Fellows of Harvard College Fluorocarbon emulsion stabilizing surfactants
ES2375453T3 (es) * 2006-09-07 2012-03-01 Universitätsklinikum Hamburg-Eppendorf Método para la detección de células epiteliales cancerosas utilizando citoqueratinas liberadas como marcadores para dichas células.
AU2007309504B2 (en) * 2006-10-23 2012-09-13 Pacific Biosciences Of California, Inc. Polymerase enzymes and reagents for enhanced nucleic acid sequencing
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US8592221B2 (en) 2007-04-19 2013-11-26 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
WO2009018446A1 (en) * 2007-08-01 2009-02-05 The Johns Hopkins University Esophageal cancer markers
MX2010005811A (es) * 2007-11-27 2010-06-09 Veridex Llc Enumeracion automatica y caracterizacion de las celulas del melanoma circulantes en la sangre.
CA2760050A1 (en) * 2008-05-13 2009-11-19 Thomas Jefferson University Guanylyl cyclase c qrt-pcr
US12038438B2 (en) 2008-07-18 2024-07-16 Bio-Rad Laboratories, Inc. Enzyme quantification
EP4047367A1 (en) 2008-07-18 2022-08-24 Bio-Rad Laboratories, Inc. Method for detecting target analytes with droplet libraries
LT2562268T (lt) 2008-09-20 2017-04-25 The Board Of Trustees Of The Leland Stanford Junior University Neinvazinis fetalinės aneuploidijos diagnozavimas sekvenavimu
US9782565B2 (en) 2008-10-01 2017-10-10 Covidien Lp Endoscopic ultrasound-guided biliary access system
US9332973B2 (en) 2008-10-01 2016-05-10 Covidien Lp Needle biopsy device with exchangeable needle and integrated needle protection
US8968210B2 (en) 2008-10-01 2015-03-03 Covidien LLP Device for needle biopsy with integrated needle protection
US11298113B2 (en) 2008-10-01 2022-04-12 Covidien Lp Device for needle biopsy with integrated needle protection
US9186128B2 (en) 2008-10-01 2015-11-17 Covidien Lp Needle biopsy device
EP2677036A3 (en) 2009-02-25 2014-01-22 Diagnocure Inc. Method for predicting the risk of cancer recurrence
US8528589B2 (en) 2009-03-23 2013-09-10 Raindance Technologies, Inc. Manipulation of microfluidic droplets
WO2011042564A1 (en) 2009-10-09 2011-04-14 Universite De Strasbourg Labelled silica-based nanomaterial with enhanced properties and uses thereof
WO2011066048A1 (en) 2009-10-22 2011-06-03 Thomas Jefferson University Cell-based anti-cancer compositions and methods of making and using the same
CA2774032C (en) 2009-10-23 2019-03-26 Millennium Pharmaceuticals, Inc. Anti-gcc antibody molecules and related compositions and methods
WO2011057002A2 (en) * 2009-11-05 2011-05-12 Sequent Medical Inc. Multiple layer filamentary devices or treatment of vascular defects
GB0920014D0 (en) * 2009-11-13 2009-12-30 Medical Res Council Cell sampling device
US8187979B2 (en) * 2009-12-23 2012-05-29 Varian Semiconductor Equipment Associates, Inc. Workpiece patterning with plasma sheath modulation
WO2011079176A2 (en) 2009-12-23 2011-06-30 Raindance Technologies, Inc. Microfluidic systems and methods for reducing the exchange of molecules between droplets
US9217032B2 (en) * 2010-01-08 2015-12-22 Les Laboratoires Servier Methods for treating colorectal cancer
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
WO2011100604A2 (en) 2010-02-12 2011-08-18 Raindance Technologies, Inc. Digital analyte analysis
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
NZ602992A (en) 2010-03-24 2014-11-28 Servier Lab Prophylaxis of colorectal and gastrointestinal cancer
JP5856048B2 (ja) 2010-04-06 2016-02-09 国立大学法人 鹿児島大学 N結合型糖鎖を利用した消化器癌の検査方法
WO2012045012A2 (en) 2010-09-30 2012-04-05 Raindance Technologies, Inc. Sandwich assays in droplets
WO2012109600A2 (en) 2011-02-11 2012-08-16 Raindance Technologies, Inc. Methods for forming mixed droplets
WO2012112804A1 (en) 2011-02-18 2012-08-23 Raindance Technoligies, Inc. Compositions and methods for molecular labeling
ES2739623T3 (es) 2011-03-17 2020-02-03 Cernostics Inc Sistemas y composiciones para diagnosticar el esófago de Barrett y métodos para usarlos
CN102311458A (zh) * 2011-05-31 2012-01-11 江苏省原子医学研究所 一种99mTcO核标记的苯丁酸氮芥类配合物、其制备分离纯化方法及其用途
EP3709018A1 (en) 2011-06-02 2020-09-16 Bio-Rad Laboratories, Inc. Microfluidic apparatus for identifying components of a chemical reaction
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
JPWO2013031756A1 (ja) * 2011-08-29 2015-03-23 東レ株式会社 大腸癌または食道癌の検出用マーカー及び検査方法
JP2013083490A (ja) 2011-10-06 2013-05-09 Kagoshima Univ 消化器癌診断用マーカー、および消化器癌の検査方法
WO2013120089A1 (en) 2012-02-10 2013-08-15 Raindance Technologies, Inc. Molecular diagnostic screening assay
US9156915B2 (en) 2012-04-26 2015-10-13 Thomas Jefferson University Anti-GCC antibody molecules
SG11201406855TA (en) 2012-04-27 2014-11-27 Millennium Pharm Inc Anti-gcc antibody molecules and use of same to test for susceptibility to gcc-targeted therapy
EP3524693A1 (en) 2012-04-30 2019-08-14 Raindance Technologies, Inc. Digital analyte analysis
EP2867375B1 (en) 2012-06-27 2019-02-27 Berg LLC Use of markers in the diagnosis and treatment of prostate cancer
US9396532B2 (en) * 2012-11-15 2016-07-19 Siemens Healthcare Diagnostics, Inc. Cell feature-based automatic circulating tumor cell detection
CA2902757A1 (en) * 2013-02-28 2014-09-04 Millennium Pharmaceuticals, Inc. Administration of an anti-gcc antibody-drug conjugate and a dna damaging agent in the treatment of cancer
EP2986762B1 (en) 2013-04-19 2019-11-06 Bio-Rad Laboratories, Inc. Digital analyte analysis
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US20150104392A1 (en) 2013-10-04 2015-04-16 Aptose Biosciences Inc. Compositions, biomarkers and their use in the treatment of cancer
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
EP3090063B1 (en) 2013-12-31 2019-11-06 Bio-Rad Laboratories, Inc. Method for detection of latent retrovirus
WO2015138889A1 (en) * 2014-03-13 2015-09-17 The Penn State Research Foundation Compositions and methods for diagnosing barrett's esophagus stages
KR102657306B1 (ko) 2014-12-08 2024-04-12 버그 엘엘씨 전립선암의 진단 및 치료에서 필라민을 포함하는 마커의 용도
EP3271397B1 (en) 2015-03-18 2021-03-03 The Johns Hopkins University Inhibitory monoclonal antibody targeting potassium channel kcnk9
CA2994256A1 (en) 2015-07-31 2017-02-09 The Johns Hopkins University Methods and compositions for treating metabolic reprogramming disorders
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
AU2016359685B2 (en) 2015-11-25 2022-12-22 Cernostics, Inc. Methods of predicting progression of Barrett's esophagus
GB201604806D0 (en) * 2016-03-22 2016-05-04 Singapore Volition Pte Ltd Method of identifying a cancer of unknown origin
CN106124764B (zh) * 2016-08-12 2018-03-09 上海市嘉定区中心医院 以hoxb9和pbx1作为生物标志物的胃癌检测试剂盒及应用
BR112019019022A2 (pt) * 2017-03-14 2020-04-22 Novomics Co Ltd sistema para a previsão de prognósticos e benefícios da quimioterapia adjuvante para pacientes com câncer gástrico em estágios ii e iii
EP3668533A4 (en) * 2017-08-18 2022-06-15 Thomas Jefferson University PROTECTION OF NORMAL TISSUE IN CANCER TREATMENT
US10998178B2 (en) 2017-08-28 2021-05-04 Purdue Research Foundation Systems and methods for sample analysis using swabs
WO2019041045A1 (en) 2017-09-01 2019-03-07 The Hospital For Sick Children PROFILING AND TREATMENT OF HYPERMUTANT CANCER
CN111417395A (zh) 2017-10-30 2020-07-14 艾普托斯生物科学公司 用于治疗癌症的芳基咪唑
FI128634B (en) * 2019-06-07 2020-09-15 Nokia Solutions & Networks Oy Obtaining information
WO2021224705A1 (en) * 2020-05-05 2021-11-11 Nokia Technologies Oy Measurement configuration for local area machine learning radio resource management
TW202237639A (zh) 2020-12-09 2022-10-01 日商武田藥品工業股份有限公司 鳥苷酸環化酶c(gcc)抗原結合劑之組成物及其使用方法
TW202237638A (zh) 2020-12-09 2022-10-01 日商武田藥品工業股份有限公司 烏苷酸環化酶c(gcc)抗原結合劑之組成物及其使用方法

Family Cites Families (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3130883A (en) * 1962-03-01 1964-04-28 Lewis J Mackool Hatchet scabbard
US4375414A (en) 1971-05-20 1983-03-01 Meir Strahilevitz Immunological methods for removing species from the blood circulatory system and devices therefor
US4022878A (en) 1972-05-15 1977-05-10 Biological Developments, Inc. Methods and compounds for producing specific antibodies
US4526716A (en) 1981-11-20 1985-07-02 The Ohio State University Antigenic modification of polypeptides
US4329281A (en) 1978-06-05 1982-05-11 Hoffmann-La Roche Inc. Hapten compositions
US4264024A (en) * 1978-12-21 1981-04-28 Harris Jr Ellsworth L Smoking pipe sling
US4341763A (en) 1981-03-10 1982-07-27 Smithkline-Rit Methods of vaccinating humans against rotavirus infection
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4584268A (en) 1981-10-13 1986-04-22 Ceriani Roberto Luis Method and compositions for carcinoma diagnosis
US4867973A (en) 1984-08-31 1989-09-19 Cytogen Corporation Antibody-therapeutic agent conjugates
GB8328918D0 (en) 1983-10-28 1983-11-30 Unilever Plc Alkaline phosphatase
ZA839512B (en) 1983-12-12 1984-08-29 Scripps Clinic Res Synthetic heat-stable enterotoxin polypeptide of escherichia coli and multimers thereof
US4601896A (en) 1984-03-21 1986-07-22 Mark Nugent Pharmaceutical capsule compositions and structures for gastric sensitive materials
US4736866B1 (en) 1984-06-22 1988-04-12 Transgenic non-human mammals
US4945050A (en) 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US4729893A (en) 1984-12-26 1988-03-08 Robert L. Letcher Enteric encapsulation of ancrod for oral administration
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
GB8508845D0 (en) 1985-04-04 1985-05-09 Hoffmann La Roche Vaccinia dna
US5160723A (en) 1985-04-19 1992-11-03 Sloan-Kettering Institute For Cancer Research Method of imaging colorectal carcinoma lesion and composition for use therein
GB8519457D0 (en) 1985-08-02 1985-09-11 Faulk Ward Page Tumour imaging agents
JPS62162963A (ja) 1986-01-10 1987-07-18 Sadao Shiosaka 金属コロイド粒子を担体とする低分子物質に対する特異抗体の作成法
US4849227A (en) 1986-03-21 1989-07-18 Eurasiam Laboratories, Inc. Pharmaceutical compositions
IN165717B (ja) 1986-08-07 1989-12-23 Battelle Memorial Institute
US5166320A (en) 1987-04-22 1992-11-24 University Of Connecticut Carrier system and method for the introduction of genes into mammalian cells
US5399347A (en) 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
US5133866A (en) 1988-03-24 1992-07-28 Terrapin Technologies, Inc. Method to identify analyte-bending ligands
US5217869A (en) 1987-10-13 1993-06-08 Terrapin Technologies, Inc. Method to produce immunodiagnostic reagents
US4963263A (en) 1988-03-24 1990-10-16 Terrapin Technologies, Inc. Method of identity analyte-binding peptides
US5340474A (en) 1988-03-24 1994-08-23 Terrapin Technologies, Inc. Panels of analyte-binding ligands
US5350741A (en) 1988-07-30 1994-09-27 Kanji Takada Enteric formulations of physiologically active peptides and proteins
US4923949A (en) 1988-08-03 1990-05-08 Kanegafuchi Chemical Industry Co., Ltd. Ethynylene-disilanylene copolymers and method of preparing same
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5075216A (en) 1988-09-23 1991-12-24 Cetus Corporation Methods for dna sequencing with thermus aquaticus dna polymerase
US5049656A (en) 1988-12-21 1991-09-17 Board Of Regents Of The University Of Nebraska Sequential peptide and oligonucleotide syntheses using immunoaffinity techniques
DE69034078T2 (de) 1989-03-21 2004-04-01 Vical, Inc., San Diego Expression von exogenen Polynukleotidsequenzen in Wirbeltieren
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5424186A (en) 1989-06-07 1995-06-13 Affymax Technologies N.V. Very large scale immobilized polymer synthesis
US5443816A (en) 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
US5271961A (en) 1989-11-06 1993-12-21 Alkermes Controlled Therapeutics, Inc. Method for producing protein microspheres
US5252743A (en) 1989-11-13 1993-10-12 Affymax Technologies N.V. Spatially-addressable immobilization of anti-ligands on surfaces
US5366862A (en) 1990-02-14 1994-11-22 Receptor Laboratories, Inc. Method for generating and screening useful peptides
CA2039517C (en) 1990-04-03 2006-11-07 David Segev Dna probe signal amplification
US5430138A (en) * 1990-07-27 1995-07-04 Chiron Corporation Hydroxyl-protecting groups attached to cytidine nucleotide compounds which are orthogonally removable
US5237051A (en) 1990-12-06 1993-08-17 Vanderbilt University Purified enterotoxin receptor protein
US5352775A (en) 1991-01-16 1994-10-04 The Johns Hopkins Univ. APC gene and nucleic acid probes derived therefrom
EP0572563A4 (en) 1991-02-21 1993-12-29 Smithkline Beecham Corporation Treatment of esophageal cancer
US5330892A (en) 1991-03-13 1994-07-19 The Johns Hopkins University MCC gene (mutated in colorectal cancer) used for diagnosis of cancer in humans
AU662906B2 (en) * 1991-06-26 1995-09-21 F. Hoffmann-La Roche Ag Methods for detection of carcinoma metastases by nucleic acid amplification
US5140102A (en) * 1991-09-23 1992-08-18 Monsanto Company Pentadecapeptide, guanylin, which stimulates intestinal guanylate cyclase
US5270170A (en) 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
US5384261A (en) 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
US5412087A (en) 1992-04-24 1995-05-02 Affymax Technologies N.V. Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces
US5395750A (en) 1992-02-28 1995-03-07 Hoffmann-La Roche Inc. Methods for producing proteins which bind to predetermined antigens
US5969097A (en) * 1992-06-23 1999-10-19 G. D. Searle & Co. Human guanylin
US5585479A (en) 1992-07-24 1996-12-17 The United States Of America As Represented By The Secretary Of The Navy Antisense oligonucleotides directed against human ELAM-I RNA
US5420328A (en) 1992-09-11 1995-05-30 Affymax Technologies, N.V. Methods for the synthesis of phosphonate esters
US5288514A (en) 1992-09-14 1994-02-22 The Regents Of The University Of California Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
US5324483B1 (en) 1992-10-08 1996-09-24 Warner Lambert Co Apparatus for multiple simultaneous synthesis
US5397639A (en) 1992-11-25 1995-03-14 Tollini; Dennis R. Securing tape
US5595739A (en) 1993-05-07 1997-01-21 Abbott Laboratories Hepatitis B virus mutants, reagents and methods for detection
US5879656A (en) * 1993-10-26 1999-03-09 Thomas Jefferson University Methods of treating metastatic colorectal cancer with ST receptor binding compounds
US5962220A (en) 1993-10-26 1999-10-05 Thomas Jefferson University Compositions that specifically bind to colorectal cells and methods of using the same
US5518888A (en) 1993-10-26 1996-05-21 Thomas Jefferson University ST receptor binding compounds and methods of using the same
DE69433564T2 (de) 1993-10-26 2004-12-23 Thomas Jefferson University Verbindungen, die kolorektale Krebszellen spezifisch binden, und Verfahren zu ihrer Verwendung
US5601990A (en) * 1994-09-13 1997-02-11 Thomas Jefferson University Methods of diagnosing colorectal tumors and metastasis thereof
US7097839B1 (en) * 1993-10-26 2006-08-29 Thomas Jefferson University ST receptor binding compounds and methods of using the same
US5489670A (en) * 1993-10-29 1996-02-06 G. D. Searle & Co. Human uroguanylin
US5885574A (en) * 1994-07-26 1999-03-23 Amgen Inc. Antibodies which activate an erythropoietin receptor
US5597909A (en) 1994-08-25 1997-01-28 Chiron Corporation Polynucleotide reagents containing modified deoxyribose moieties, and associated methods of synthesis and use
US5858011A (en) 1995-08-02 1999-01-12 The Procter & Gamble Company Disposable absorbent article having a resilient member
CA2251186A1 (en) * 1996-04-05 1997-10-16 The Johns Hopkins University A method of enriching rare cells
JP3122771B2 (ja) * 1996-04-16 2001-01-09 岸本 忠三 固形癌細胞及び組織異型性の検出方法並びに骨髄移植及び末梢血幹細胞移植用組織の検査方法
CA2254082C (en) 1996-05-03 2012-09-11 Thomas Jefferson University Metastatic colorectal cancer vaccine
US6602659B1 (en) * 1996-05-03 2003-08-05 Thomas Jefferson University Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof
US5914238A (en) * 1996-06-05 1999-06-22 Matritech, Inc. Materials and methods for detection of breast cancer
AU4003597A (en) * 1996-09-04 1998-03-26 Howard Florey Institute Of Experimental Physiology And Medicine Methods of diagnosing and treating cancer
FI971124A0 (fi) * 1997-03-18 1997-03-18 Locus Genex Oy Metod foer diagnostisering av magcancer
US5874266A (en) * 1997-03-27 1999-02-23 Palsson; Bernhard O. Targeted system for removing tumor cells from cell populations
WO1998050567A1 (en) * 1997-05-02 1998-11-12 Abbott Laboratories Reagents and methods useful for detecting diseases of the prostate
US6120995A (en) * 1997-08-07 2000-09-19 Thomas Jefferson University Compositions that specifically bind to colorectal cancer cells and methods of using the same
EP1117833A4 (en) 1998-10-02 2002-08-14 Diadexus Inc A NEW METHOD FOR DIAGNOSIS, DETERMINATION, CLASSIFICATION, DISPLAY AND TREATMENT OF GASTROINTESTINAL CANCER DISEASES
US6960449B2 (en) * 1999-02-10 2005-11-01 Cell Works Diagnostics, Inc. Class characterization of circulating cancer cells isolated from body fluids and methods of use
WO2000073479A1 (en) * 1999-05-28 2000-12-07 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services A combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector
CA2404431C (en) 2000-03-27 2011-06-07 Thomas Jefferson University Guanylyl cyclase c in the detection of stomach and esophageal cancers
US7829276B2 (en) * 2000-09-18 2010-11-09 Thomas Jefferson University Methods of using CRCA-1 as a stomach and esophageal cancer marker
US6652378B2 (en) 2001-06-01 2003-11-25 Igt Gaming machines and systems offering simultaneous play of multiple games and methods of gaming
JP2005537731A (ja) * 2002-08-30 2005-12-08 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ マルチメディアコンテンツ識別のためにフィンガープリントを埋込む方法
EP1599165A4 (en) * 2003-02-10 2010-09-08 Univ Jefferson THE USE OF GCC LIGANDS
EP2722060A3 (en) * 2004-06-25 2015-01-07 Thomas Jefferson University Guanylyl cyclase C ligands
DE102005041131B4 (de) 2005-08-30 2008-01-31 Phoenix Contact Gmbh & Co. Kg Übertrager
US9001515B2 (en) 2012-04-20 2015-04-07 Cisco Technology, Inc. Universal pull tab release for modules including fiber optic and cable accessibilities
US9707467B2 (en) 2013-10-18 2017-07-18 Under Armour, Inc. Athletic glove
US9707565B2 (en) 2014-04-09 2017-07-18 II Lyman Burdette Lyne Screen assembly for shredding machine

Similar Documents

Publication Publication Date Title
JP2003528628A5 (ja)
JP2003532389A5 (ja)
JP6630766B2 (ja) 膵臓癌診断用組成物およびこれを用いた膵臓癌診断方法
CA2404431A1 (en) Guanylyl cyclase c in the detection of stomach and esophageal cancers
Vandghanooni et al. Recent progress in the development of aptasensors for cancer diagnosis: focusing on aptamers against cancer biomarkers
US20160252512A1 (en) Composition for diagnosing pancreatic cancer and method for diagnosing pancreatic cancer using same
JP2019507594A (ja) 大腸がん診断用組成物と診断マーカー検出方法
Phadke et al. A novel and accurate microfluidic assay of CD62L in bladder cancer serum samples
KR101927350B1 (ko) 에스트로겐 수용체 및 아로마타제 수준의 측정을 통한 코눈물관협착 질환의 진단용 키트
KR101815253B1 (ko) 간 섬유화 진단용 바이오마커 cxcl14
Kim et al. Fecal occult blood test/fecal carcinoembriogenic antigen dual rapid test as a useful tool for colorectal cancer screening
JP4628098B2 (ja) 肝細胞癌を診断する方法と組成物
KR101927346B1 (ko) 에스트로겐 수용체 및 아로마타제 수준의 측정을 통한 눈물흘림증의 치료제를 스크리닝하는 방법
KR102325742B1 (ko) 암의 진단용 조성물
WO2022260166A1 (ja) 癌診断用キット及びその使用
KR101927349B1 (ko) 에스트로겐 수용체 및 아로마타제 수준의 측정을 통한 코눈물관 협착 질환의 치료제를 스크리닝하는 방법
US20230045066A1 (en) Biomarkers for diagnosing breast cancer and uses thereof
KR101927355B1 (ko) 코눈물관 관련 질환의 진단용 바이오 마커 및 그의 용도
KR101927347B1 (ko) 에스트로겐 수용체 및 아로마타제 수준의 측정을 통한 눈물흘림증의 진단용 키트
KR101927353B1 (ko) 눈물흘림증의 진단용 키트
KR101872404B1 (ko) 코눈물관 관련 질환의 진단용 바이오 마커 및 그의 용도
KR101927352B1 (ko) 코눈물관협착 질환 및 눈물흘림증의 진단용 키트
KR101927348B1 (ko) 눈물흘림증의 진단용 에스트로겐 수용체 및 아로마타제 마커 및 그의 용도
KR101927351B1 (ko) 코눈물관 협착 질환의 진단용 에스트로겐 수용체 및 아로마타제 마커 및 그의 용도
KR101927354B1 (ko) 코눈물관 협착 질환의 진단용 키트